US Patent Issued to Hangzhou Zhongmeihuadong Pharmaceutical on March 31 for "GLP-1/GIP dual agonist, preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,158, issued on March 31, was assigned to Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. (Hangzhou, China).

"GLP-1/GIP dual agonist, preparation method and use thereof" was invented by Nan Zhang (Zhejiang, China), Chunhua Jiang (Zhejiang, China), Dongzhou Liu (Zhejiang, China), Li Teng (Zhejiang, China) and Jiale Shen (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to long-acting GLP-1/GIP dual agonist compounds having a dual agonistic effect on glucagon-like peptide-1 (GLP-1) receptor and human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to the use o...